AVITA Medical, Inc.
RCEL
$4.62
-$0.265-5.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.57M | -57.05M | -61.85M | -57.32M | -49.83M |
| Total Depreciation and Amortization | 1.79M | 1.44M | 1.13M | 904.00K | 758.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 86.00K | 171.00K |
| Total Other Non-Cash Items | 13.88M | 15.41M | 16.46M | 8.54M | 4.62M |
| Change in Net Operating Assets | 70.00K | 1.81M | -4.68M | -3.93M | -9.20M |
| Cash from Operations | -35.83M | -38.38M | -48.94M | -51.72M | -53.48M |
| Capital Expenditure | -6.12M | -8.25M | -9.17M | -7.86M | -4.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.76M | 41.31M | 46.53M | -14.56M | -3.45M |
| Cash from Investing | 27.65M | 33.06M | 37.36M | -22.41M | -8.05M |
| Total Debt Issued | -- | -- | -- | 38.76M | 38.76M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.95M | 3.24M | 3.51M | 3.16M | 2.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.95M | 3.24M | 3.51M | 41.92M | 41.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -1.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.24M | -2.08M | -8.07M | -32.22M | -20.03M |